IP Library Granted Patent US 10,201,581
Granted Patent B2
US 10,201,581 · App. 15/443,675 · Granted Feb 12, 2019

Composition for cooling skin comprising phellodendron bark extract, method of preparing the same, topical composition comprising the same and dermatologically acceptable carrier, and method of cooling skin by applying the same

Inventor: Yong Kyu Woo (Suseong-gu, KR)
Assignees: Yong Kyu Woo; NATURE4 CO., LTD
A61K36/756A61K9/0014A61K33/06A61K36/18A61K36/534A61K36/539A61K36/65A61K36/75A61K36/8964A61K2236/13A61K2236/331
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,201,581
App. No.
15/443,675
Granted
Feb 12, 2019
Kind
B2
Abstract

Provided are a composition for cooling skin comprising a Phellodendron bark extract, a method of preparing the composition, a skin-improving product comprising the composition and a method of cooling skin by applying the composition to a skin of a subject, wherein the skin needs cooling. The composition prevents a burning sensation in the skin and under the skin and reduces heat generated under the skin and on the skin. The composition includes a Phellodendron bark extract as a main ingredient and further includes an extract of one or more selected from the group consisting of Anemarrhena asphodeloides, Scutellaria baicalensis, Paeonia lactiflora, Dictamnus dasycarpus, Alumen, Dryobalanops aromatic and Mentha arvensis.

Claims (33)

1. A composition comprising

a Phellodendron bark extract as a main ingredient,

a Dictamnus dasycarpus extract,

a Dryobalanops aromatic extract,

a Scutellaria baicalensis extract,

a Paeonia lactiflora extract, and

at least one compound selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, 4-hydroxybenzoic acid, 5-bromo-5-nitro-1,3-dioxane, dehydroacetic acid, dimethyl oxazolidine, diazolidinyl urea, DMDM hydantoin, dichlorobenzyl alcohol, lauralkonium chloride, laurtrimonium bromide, laurtrimonium chloride, magnesium salicylate, methylisothiazolinone, methylparaben, benzalkonium chloride, benzoic acid, benzyl alcohol, butylparaben, bromochlorophene, cetrimonium bromide, cetrimonium chloride, sodium dehydroacetate, sodium methylparaben, sodium benzoate, sodium borate, sodium salicylate, sodium formate, sodium propylparaben, sodium o-phenylphenate, sorbic acid, iodopropynyl butylcarbamate, ethylparaben, ethyl lauroyl arginate hydrochloride, undecylenic acid, imidazolidinyl urea, isobutylparaben, isopropylparaben, zinc undecylenate, zinc pyrithione, calcium propionate, quaternium-15, chlorobutanol, chloroxylenol, chlorphenesin, chlorhexidine digluconate, climbazole, triclosan, triclocarban, phenoxyethanol, phenoxyisopropanol, phenyl salicylate, formaldehyde, potassium benzoate, potassium sorbate, polyaminopropyl biguanide, propionic acid, propylparaben, piroctone olamine, hexamidine diisethionate and o-cymen-5-ol.

2. The composition of claim 1 further comprising an Anemarrhena asphodeloides extract.

3. The composition of claim 1 further comprising an extract of one or more selected from the group consisting of Anemarrhena asphodeloides, Alumen and Mentha arvensis.

4. The composition of claim 1 further comprising an extract of Anemarrhena asphodeloides, Alumen and Mentha arvensis.

5. The composition of claim 2 , wherein the Phellodendron bark extract is in an amount of 30-80% by weight and the Anemarrhena asphodeloides extract is in an amount of 20-70% by weight.

6. The composition of claim 4 , wherein the Phellodendron bark extract and the Anemarrhena asphodeloides extract are in an amount of 35-50% by weight and the extract of the Scutellaria baicalensis , the Paeonia lactiflora , the Dictamnus dasycarpus , the Alumen , the Dryobalanops aromatic and the Mentha arvensis are in an amount of 50-65% by weight.

7. The composition of claim 4 , wherein the Phellodendron bark extract is in an amount of 15-35% by weight, the Anemarrhena asphodeloides extract is in an amount of 10-23% by weight, the Scutellaria baicalensis extract is in an amount of 3-15% by weight, the Paeonia lactiflora extract is in an amount of 12-25% the Dictamnus dasycarpus extract is in an amount of 7-15% by weight, the Alumen extract is in an amount of 12-25% by weight, the Dryobalanops aromatic extract is in an amount of 0.7-5% by weight, and the Mentha arvensis extract is in an amount of 1-7% by weight.

8. The composition of claim 1 further comprising an extract of Scutellaria baicalensis, Paeonia lactiflora and Mentha arvensis.

9. The composition of claim 8 , wherein the Phellodendron bark extract is in an amount of 15-60% by weight, the Scutellaria baicalensis extract is in an amount of 3-30% by weight, the Paeonia lactiflora extract is in an amount of 12-50% by weight and the Mentha arvensis extract is in an amount of 5-25% by weight.

10. A topical composition comprising the composition of claim 1 and a dermatologically acceptable carrier.

11. A topical composition comprising the composition of claim 2 and a dermatologically acceptable carrier.

12. A topical composition comprising the composition of claim 3 and a dermatologically acceptable carrier.

13. A topical composition comprising the composition of claim 4 and a dermatologically acceptable carrier.

14. A topical composition comprising the composition of claim 8 and a dermatologically acceptable carrier.

15. A method of cooling skin comprising:

applying a composition, comprising a Phellodendron bark extract as a main ingredient, a Dictamnus dasycarpus extract, a Dryobalanops aromatic extract, a Scutellaria baicalensis extract, and a Paeonia lactiflora extract to a skin of a subject, wherein the skin needs cooling.

16. The method of claim 15 , wherein the composition further comprises an Anemarrhena asphodeloides extract.

17. The method of claim 15 , wherein the composition further comprises an extract of one or more selected from the group consisting of Anemarrhena asphodeloides, Alumen, Dryobalanops aromatic and Mentha arvensis.

18. The method of claim 15 wherein the composition further comprises an extract of Anemarrhena asphodeloides, Alumen, Dryobalanops aromatic and Mentha arvensis.

19. The method of claim 16 , wherein the Phellodendron bark extract is in an amount of 30-80% by weight and the Anemarrhena asphodeloides extract is in an amount of 20-70% by weight.

20. The method of claim 18 , wherein the Phellodendron bark extract and the Anemarrhena asphodeloides extract are in an amount of 35-50% by weight and the extract of the Scutellaria baicalensis , the Paeonia lactiflora , the Dictamnus dasycarpus , the Alumen , the Dryobalanops aromatic and the Mentha arvensis are in an amount of 50-65% by weight.

21. The method of claim 18 , wherein the Phellodendron bark extract is in an amount of 15-35% by weight, the Anemarrhena asphodeloides extract is in an amount of 10-23% by weight, the Scutellaria baicalensis extract is in an amount of 3-15% by weight, the Paeonia lactiflora extract is in an amount of 12-25% the Dictamnus dasycarpus extract is in an amount of 7-15% by weight, the Alumen extract is in an amount of 12-25% by weight, the Dryobalanops aromatic extract is in an amount of 0.7-5% by weight, and the Mentha arvensis extract is in an amount of 1-7% by weight.

22. The method of claim 15 , wherein the composition further comprises an extract of Scutellaria baicalensis, Paeonia lactiflora and Mentha arvensis.

23. The method of claim 15 , wherein the skin comprises scrotum skin.

24. The method of claim 15 , wherein the skin comprises scalp.

25. The composition of claim 1 further comprising a Lonicera japonica extract.

26. The method of claim 15 , wherein the composition further comprises a Lonicera japonica extract.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2017
From: WOO, YONG KYU
To: WOO, YONG KYU; NATURE4 CO., LTD
Reel/Frame 041387/0218 →
Priority Claims (1)
KR 10-2014-0112062 · Aug 27, 2014 · national
Continuity (2)
Continuation In Part PCTKR2015005077 · May 21, 2015
Related Publication 20170165311A1 · Jun 15, 2017
Cited By (2)
US 12,357,594 US 12,702,585